摘要
第82届美国糖尿病学会(American Diabetes Association)学术会议于2022年6月3日在美国新奥尔良正式召开。本次会议采取线上、线下结合的形式,内容涵盖了糖尿病研究、预防和治疗方面的最新前沿进展,其中不乏有我国研究者的最新研究成果亮相。本篇会议纪要精选了大会的重要研究成果,包括大会奖项颁布、药物研究进展、并发症/合并症的管理、指南/共识更新、以及其他代谢性疾病进展,以期为我国糖尿病的临床管理提供参考价值。
The 82nd American Diabetes Association Academic Meeting was held in New Orleans,U.S.A.on June 3,2022.The meeting had both in-person and virtual activities,encompassed the advances in diabetes study,prevention,and management,including the latest research results of Chinese researchers.This summary highlights the important research findings,including congress awards,drug research progress,management of complications/comorbidities,update of guideline/consensus,and progress of other metabolic diseases,with an aim to provide reference for diabetes management in China.
作者
王绵
王中京
Wang Mian;Wang Zhongjing(Department of Endocrinology,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;The Central Hospital of Wuhan,Wuhan 430014,China)
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2023年第1期72-76,共5页
Chinese Journal of Endocrinology and Metabolism